长非编码RNA在瘤耐药性的研究进展:一个新的范式
Jing Zhang1, Le Wu1, Chenchen Wang2
1Laboratory of Tissue Engineering, Faculty of Life Science, Northwest University, Xi'an, Shaanxi, People's Republic of China.
Drug design, development and therapy
|May 1, 2024
概括
长非编码RNAs (lncRNAs) 通过影响生物过程,有助于癌症抗药性. 了解lncRNA机制是克服耐药性和改进向癌症治疗的关键.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 基因组学就是基因组学.
背景情况:
- 化疗是一种主要的癌症治疗方法,但耐药性仍然是一个重大挑战.
- 癌症耐药性的机制是复杂的,并未完全理解.
- 长非编码RNAs (lncRNAs) 是新发现的基因组元素,参与各种细胞过程.
研究的目的:
- 审查 lncRNAs 在调解向癌症药物耐药性的作用.
- 阐明 lncRNAs 导致药物耐药性的机制.
- 为开发针对抗药性瘤的新型向治疗提供理论基础.
主要方法:
- 本综述综合了关于 lncRNAs 和癌症药物耐药性的当前研究.
- 专注于研究研究高死亡率瘤中的lncRNA表达和功能.
- 检查影响药物反应的遗传和表观遗传因素.
主要成果:
- lncRNAs的异常表达被认为是癌症抗药性的一个因素.
- lncRNAs影响关键的生物过程,包括转录,表观遗传学和细胞周期调节.
- 代谢基因中的遗传变异和多态性也会影响患者的治疗反应.
结论:
- lncRNAs代表了理解和克服癌症耐药性的重要研究领域.
- 准 lncRNAs 有望开发更有效的癌症治疗方法.
- 对lncRNA机制的进一步研究对于推进向癌症治疗至关重要.
更多相关视频
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
10.6K
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
7.2K
相关概念视频
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Loss of Tumor Suppressor Gene Functions
4.8K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.8K
